RecruitingNot ApplicableNCT04611867

Study of PRO in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)

Study of Supportive Application with Integrated Patient-Reported Outcomes in Patients with Advanced Pancreatic or BiliaryTract Cancer (BetterEveryDay)

Sponsor

Inna Chen, MD

Enrollment

274 participants

Start Date

Aug 17, 2021

Study Type

INTERVENTIONAL

Conditions

Pancreatic Cancer Lung Cancer, Nonsmall Cell

Summary

Pancreatic and biliary tract cancer are ones of the leading causes of cancer-related deaths. During the course of illness, these patients often experience marked physical suffering, psychological distress and frequent unplanned resource-demanding hospitalized care. Patients with pancreatic and lung cancer have highest rates of unplanned hospitalizations. Investigator initiated prospective "Study of Supportive Application with Integrated Patient-Reported Outcomes in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)" is to be initiated based on the great need for optimizing treatment care, reducing hospitalizations and improving outcomes.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study (called BetterEveryDay) is exploring how tracking patients' own daily symptom reports (called patient-reported outcomes) through a digital app might help doctors better manage advanced lung or pancreatic cancer treatment. It does not test a new drug — it tests a new way of monitoring wellbeing during treatment. **You may be eligible if...** - You are 18 or older - You have confirmed advanced non-small cell lung cancer or pancreatic cancer - You are about to start your first line of cancer treatment - You are in good enough health to participate (ECOG 0–2) - You have access to the internet and a mobile device - You can read and respond to questionnaires **You may NOT be eligible if...** - You do not have access to a mobile device - You have signs of significant cognitive or psychiatric problems - You are already enrolled in another interventional clinical trial Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSupportive application with integrated weekly PRO

Patients will fill in a web-based application PRO-CTCAE with integrated preparation questionnaire every week. If their weekly reported symptoms exceed a predefined threshold of severity, this results in a notification on the staff application interface and a nurse will contact a patient for verification of symptoms. Nurse will review patient recent treatment and PRO reports and advise patient according to the local practice for symptom management and reinforce reporting. Nurse will consult with or refers to (if possible) treating physician if patient will require medical intervention and/or physician assistance.

Locations(1)

Herlev & Gentofte University Hospital, Denmark

Herlev, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04611867

Related Trials

DESTINY-PANTUMOUR04

NCT0712400017 locations

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

NCT0725223217 locations

Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery

NCT054283583 locations

In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers

NCT072063551 location

Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers

NCT028388361 location